These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8545275

  • 1. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
    Rajan R, Vanderslice R, Kapur S, Lynch J, Thompson R, Djakiew D.
    Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
    Zolfaghari A, Djakiew D.
    Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
    [Abstract] [Full Text] [Related]

  • 3. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.
    Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M.
    Cancer Res; 1991 Jun 15; 51(12):3304-10. PubMed ID: 1710170
    [Abstract] [Full Text] [Related]

  • 4. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein.
    Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand G, Thompson EW.
    Cancer Res; 1993 Mar 15; 53(6):1416-20. PubMed ID: 8443820
    [Abstract] [Full Text] [Related]

  • 5. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
    Lee HL, Pienta KJ, Kim WJ, Cooper CR.
    Int J Oncol; 2003 Apr 15; 22(4):921-6. PubMed ID: 12632088
    [Abstract] [Full Text] [Related]

  • 6. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
    Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2003 Mar 15; 9(3):1200-10. PubMed ID: 12631626
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P, Royuela, Bethencourt R, Ruiz A, Fraile B, Paniagua R.
    Cytokine; 1999 Sep 15; 11(9):722-7. PubMed ID: 10479409
    [Abstract] [Full Text] [Related]

  • 8. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
    Pflug BR, Onoda M, Lynch JH, Djakiew D.
    Cancer Res; 1992 Oct 01; 52(19):5403-6. PubMed ID: 1382843
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 10. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.
    Jacob K, Webber M, Benayahu D, Kleinman HK.
    Cancer Res; 1999 Sep 01; 59(17):4453-7. PubMed ID: 10485497
    [Abstract] [Full Text] [Related]

  • 11. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro.
    Duque JL, Adam RM, Mullen JS, Lin J, Richie JP, Freeman MR.
    J Urol; 2001 Jan 01; 165(1):284-8. PubMed ID: 11125426
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T, Dutcher JP, Dempster DW, Wiernik PH.
    Prostate; 2004 Jun 15; 60(1):1-17. PubMed ID: 15129424
    [Abstract] [Full Text] [Related]

  • 13. Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone.
    Enomoto M, Seong JY, Kawashima S, Park MK.
    Life Sci; 2004 May 07; 74(25):3141-52. PubMed ID: 15081579
    [Abstract] [Full Text] [Related]

  • 14. Stromal factors involved in prostate carcinoma metastasis to bone.
    Cooper CR, Chay CH, Gendernalik JD, Lee HL, Bhatia J, Taichman RS, McCauley LK, Keller ET, Pienta KJ.
    Cancer; 2003 Feb 01; 97(3 Suppl):739-47. PubMed ID: 12548571
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
    Kim SJ, Uehara H, Yazici S, Langley RR, He J, Tsan R, Fan D, Killion JJ, Fidler IJ.
    Cancer Res; 2004 Jun 15; 64(12):4201-8. PubMed ID: 15205332
    [Abstract] [Full Text] [Related]

  • 16. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW, Baseman A, Assikis V, Zhau HE.
    J Urol; 2005 Jan 15; 173(1):10-20. PubMed ID: 15592017
    [Abstract] [Full Text] [Related]

  • 17. Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors.
    Liu Z, Klominek J.
    Anticancer Res; 2004 Jan 15; 24(3a):1625-30. PubMed ID: 15274332
    [Abstract] [Full Text] [Related]

  • 18. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ.
    Cancer Res; 2003 Jun 01; 63(11):2940-7. PubMed ID: 12782601
    [Abstract] [Full Text] [Related]

  • 19. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R, Djakiew D.
    J Androl; 1996 Jun 01; 17(5):481-90. PubMed ID: 8957691
    [Abstract] [Full Text] [Related]

  • 20. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells.
    Angelucci A, Festuccia C, Gravina GL, Muzi P, Bonghi L, Vicentini C, Bologna M.
    Prostate; 2004 May 01; 59(2):157-66. PubMed ID: 15042616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.